Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
107,228,372
-
Number of holders
-
187
-
Total 13F shares, excl. options
-
91,974,687
-
Shares change
-
+4,195,335
-
Total reported value, excl. options
-
$2,477,726,425
-
Value change
-
+$110,873,444
-
Put/Call ratio
-
46%
-
Number of buys
-
85
-
Number of sells
-
86
-
Price
-
$26.94
Institutional Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) as of Q1 2024
As of 31 Mar 2024 ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) had 230 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 91,974,687 shares of stock of the company.
Largest 10 holders included RTW INVESTMENTS, LP, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, WESTFIELD CAPITAL MANAGEMENT CO LP, MAVERICK CAPITAL LTD, PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, and CITADEL ADVISORS LLC.
This table shows 230 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.